Does Ginkgo biloba increase the risk of bleeding? A systematic review of case reports

Perfusion

Volumn 18, Issue 2, 2005, Pages 52-56

  Ernst, E ^a   Canter, P H ^a   Thompson Coon, J ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Adverse effects; Bleeding; Ginkgo biloba; Herb drug interactions; Herbal medicine

Indexed keywords

EID: 24944497781     PISSN: 09350020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Blumenthal M. Herb sales down in mainstream market, up in natural food stores. Herbalgram 2002;55:60
2. DeFeudis FV. Ginkgo biloba extract. From chemistry to the clinic. Wiesbaden: Ullstein, 1998
3. Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of double-blind placebo-controlled trials. Clin Drug Invest 1999;17:301-308
4. Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992;34:352-358
5. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication. A meta-analysis. Am J Med 2000;108:276-281
6. Fugh-Berman A. The 5-minute herbal and dietary supplement consult. Philadelphia: Lippincott, Williams & Wilkins, 2003
7. Capasso F, Gaginella TS, Grandolini G, Izzo AA. Phytotherapy. A quick reference to herbal medicine. Berlin, Heidelberg, New York: Springer-Verlag, 2003
8. Ernst E, Pittler MH, Stevinson C, White AR. The desktop guide to complementary and alternative medicine. Edinburgh: Mosby, 2001
9. Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587-595
10. Scott GN, Elmer GW. Update on natural product-drug interactions. Am J Health-Syst Pharm 2002;59:339-347
11. Coxeter PD, McLachlan AJ, Duke CC, Roufogalis BD. Ginkgo biloba interactions. Complementary medicine 2003;May/June:70-72
12. Barnes J, Anderson LA, Phillipson JD. Herbal interactions. Pharm J 2003;270:118-121
13. Valli G, Giardina E-GV. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. Cardiology 2002;39:1083-1095
14. Kuhn MA. Herbal remedies: drug-herb interactions. Critical Care Nurse 2002;22:22-32
15. Ulbricht CE. Herbs and supplements in anticoagulation. Pharmacy Practice News 2003;August:95-100
16. Gundling K, Ernst E. Herbal medicines: influences on blood coagulation. Perfusion 2001;14:336-342
17. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;15:2163-2175
18. Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctot KL, et al. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging 2002;19:879-886
19. Braquet P, Drieu K, Etienne A. Le ginkgolide B (BN 52021): un puissant inhibiteur du PAF-acéther isolé du Ginkgo biloba L. Actual Chim Thér 1986;13:237-254
20. Braquet P, Spinnewyn B, Braquet M, Bourgain RH, Taylor JE, Etienne A. BN 52021 and related compounds: a new series of highly specific PAF-acether receptor antangonists isolated from Ginkgo biloba L. Blood Vessels 1985;16:558-572
21. Chung KF, Dent G, McCusker M, Guinot P, Page CP, Barnes PJ. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1987;1:248-251
22. Wilkens JH. Effects of PAF-antagonist on bronchoconstriction and platelet activation during exercise induced asthma. Br J Clin Pharmacol 1990;29:85-91
23. Rowin J, Lewis SL. Spontaneous bilateral subdural haematomas associated with chronic Ginkgo biloba ingestion. Neurol 1996;46:1775-1776
24. Gilbert GJ. Ginkgo biloba. Neurol 1997;48:1137
25. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998;352:36
26. Vale S. Extracts of Ginkgo biloba and bleeding or haemorrhage. Lancet 1998;352:1146
27. Benjamin J, Muir T, Briggs K, Pentland B. A case of cerebral haemorrhage - can Ginkgo biloba be implicated? Postgrad Med J 2001;77:112-113
28. Fessenden JM, Wittenborn W, Clarke L. Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 2001;67:33-35
29. García FP, Molina C, Sabín JA. Hemorragia cerebelosa espontánea asociada a la ingestión de Ginkgo biloba. Med Clin (Barc) 2002;119:596-597
30. Hauser D, Gayowski T, Singh N. Bleeding complications precipitated by unrecognized Ginkgo biloba use after liver transplantation. Transpl Int 2002;15:377-379
31. Miller LG, Freeman B. Possible subdural hematoma associated with Ginkgo biloba. J Herbal Pharmacother 2002;2:57-63
32. Fong KCS, Kinnear PE. Retrobulbar haemorrhage associate with chronic Ginkgo biloba ingestion. Postgrad Med J 2003;79:531-532
33. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract (letter). N Eng J Med 1997;336:1108
34. Mathews MN. Association of ginkgo biloba with intracerebral haemorrhage. Neurol 1998;50:1933-1934
35. Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Artherosclerosis 2003;167:367
36. Z'Brun A. Ginkgo - Dichtung und Wahrheit. Schweiz Rundsch Med Prax 1995;84:1-6
37. Schwabe U, Paffrath D. Arzneiverordnungsreport 1999. Berlin: Springer, 2000
38. Guinot P, Caffrey E, Lambe R, Darragh A. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers. Haemostasis 1989;19:219-223
39. Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Drug Res 1990;40:589-593
40. Kiesewetter H, Jung F, Mrowietz C, Wenzel E. Hemorrheological and circulatory effects of Gincosan. Int J Clin Pharmacol Ther Tox 1992;30:97-102
41. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double-blind, placebo-crossover trial. Thromb Haemost 2002;87:1075-1076
42. Kudolo GB, Dorsey S, Blodgett J. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. Thromb Res 2003;108:151-160
43. Bal Dit Sollier C, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haem 2003;25:251-253
44. DeKosky ST, Schneider LS, Farlow MR, Tariot PN, Kieser M, Hoerr R. Ginkgo biloba extract EGb761® did not alter blood coagulation and bleeding time in a sample of elderly people with probable Alzheimer's disease. (2005, in press)
45. Köhler S, Funk P, Kieser M. Influence of Ginkgo biloba special extract EGb761® on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coag Fibrinol 2004;15:303-309
46. Wolf HRD. Effect of Ginkgo biloba special extract EGb 761® and acetylsalicylic acid on coagulation: a randomized, double-blind, double-dummy, crossover study in healthy subjects. G. biloba extract (in preparation)